Sofosbuvir/ledipasvir and AbbVie 3D regimen cure most people with HCV genotype 4

da | postato in: Senza categoria | 0

Sofosbuvir/ledipasvir without
ribavirin and AbbVie’s 3D regimen (paritaprevir/ombitasvir plus dasabuvir) both
produced high sustained virological response rates for people with hepatitis C
virus (HCV) genotype 4, according to a pair of studies presented at the American Association for the Study of Liver
Diseases (AASLD) Liver Meeting this week in Boston, USA.
HCV genotype 4, the
most